©The Author(s) 2019.
World J Gastroenterol. Aug 21, 2019; 25(31): 4452-4467
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4452
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4452
Table 1 Relationship between APChigh and clinical characteristic and known prognostic genes
| Characteristic | APChigh | APClow | P-value |
| Age | 66 ± 8 | 61 ± 9 | 0.084 |
| Stage | |||
| I | 5 | 25 | 0.031 |
| II | 10 | 12 | 1 |
| III + IV | 29 | 7 | 0.043 |
| Grade | |||
| 1 | 4 | 33 | 0.031 |
| 2 | 15 | 5 | 0.047 |
| 3 | 25 | 6 | 0.039 |
| Lymph node metastasis | |||
| N0 | 7 | 23 | 0.027 |
| N1 | 10 | 12 | 1 |
| N2 | 11 | 4 | 0.031 |
| N3 | 16 | 5 | 0.035 |
| Distant metastasis | |||
| M0 | 7 | 9 | 0.781 |
| M1 | 37 | 35 | 0.812 |
| Gene | |||
| KIT | 29 | 15 | 0.031 |
| PIK3CA | 32 | 12 | <0.001 |
| KRAS | 28 | 16 | 0.038 |
| MLH1 | 28 | 16 | 0.038 |
- Citation: Du WB, Lin CH, Chen WB. High expression of APC is an unfavorable prognostic biomarker in T4 gastric cancer patients. World J Gastroenterol 2019; 25(31): 4452-4467
- URL: https://www.wjgnet.com/1007-9327/full/v25/i31/4452.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i31.4452